This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04588/identifier/chemspider/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04588/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04588/identifier/bindingdb/
owlhttp://www.w3.org/2002/07/owl#
n14http://linked.opendata.cz/resource/drugbank/drug/DB04588/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04588/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04588/identifier/drugbank/

Statements

Subject Item
n2:DB04588
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB04588 n15:DB04588
dcterms:title
N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
adms:identifier
n9:20120291 n10:DB04588 n11:15399 n12:46506992 n13:2DD n14:5327104
n5:IUPAC-Name
n6:271B4109-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B410F-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B410E-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B410B-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B410C-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B410D-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4107-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4108-363D-11E5-9242-09173F13E4C5 n6:271B4105-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4106-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4115-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4116-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4110-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4111-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4113-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4112-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4114-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B411B-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B411D-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B411E-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B411A-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4119-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B411C-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B410A-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4117-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4118-363D-11E5-9242-09173F13E4C5